The biochemistry is sound
The biotech also has a once-daily dual GLP-1/GIP injectable (yes, daily) thats in Phase 2 trials and would treat obese or overweight patients with type 1 diabetes
GLP-1s are predicted to become the best-selling drug class of 2024 (inclusive of diabetes and obesity) 2 The late-stage obesity pipeline is dominated by big pharma, and 8 of the top 20 pharma companies have a clinical stage asset in development The obesity pipeline has almost tripled in size since June 2023, and there are up to 6 new U.S
Armaghan J 2008
Studies have found that under pathological conditions, astrocytes are activated by A to produce cytoinflammatory factors, complement, oxygen free radicals, etc., which then trigger inflammation, promote nerve cell damage and death, and ultimately aggravate Alzheimers disease (Do et al., 2014
Power Jug Flip'n'Sip Blue 1890 ml from PVL is a durable, high-capacity water jug designed to support optimal hydration during intense training sessions or throughout the day